185 related articles for article (PubMed ID: 34315659)
1. A 25-year perspective on evaluation and understanding of biomarkers in urologic cancers.
Feldman AS; Lokeshwar V; Lin DW
Urol Oncol; 2021 Sep; 39(9):602-617. PubMed ID: 34315659
[TBL] [Abstract][Full Text] [Related]
2. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
4. A 25-year perspective on advances in an understanding of the biology, evaluation, treatment and future directions/challenges of urothelial cancer.
Agarwal PK; Sfakianos JP; Feldman A; Tagawa ST; Black PC
Urol Oncol; 2021 Sep; 39(9):528-547. PubMed ID: 34332848
[TBL] [Abstract][Full Text] [Related]
5. A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.
Geynisman DM; Maranchie JK; Ball MW; Bratslavsky G; Singer EA
Urol Oncol; 2021 Sep; 39(9):548-560. PubMed ID: 34092483
[TBL] [Abstract][Full Text] [Related]
6. The use of the smear of the urinary sediment in the diagnosis and management of neoplasm of the kidney and bladder. 1951.
Harrison JH; Botsford TW; Tucker MR
J Urol; 2002 Feb; 167(2 Pt 2):864-71; discussion 872. PubMed ID: 11905913
[No Abstract] [Full Text] [Related]
7. Urologic Oncology: Seminars and Original Investigations. A Twenty-Fifth Anniversary History.
Droller MJ
Urol Oncol; 2021 Sep; 39(9):506-513. PubMed ID: 33612355
[TBL] [Abstract][Full Text] [Related]
8. Screening for urologic malignancies in primary care: pros, cons, and recommendations.
Stephenson AJ; Kuritzky L; Campbell SC
Cleve Clin J Med; 2007 May; 74 Suppl 3():S6-14. PubMed ID: 17546828
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer.
Gorin MA; Verdone JE; van der Toom E; Bivalacqua TJ; Allaf ME; Pienta KJ
Nat Rev Urol; 2017 Feb; 14(2):90-97. PubMed ID: 27872478
[TBL] [Abstract][Full Text] [Related]
10. A 25-year review of advances in testicular cancer: Perspectives on evaluation, treatment, and future directions/challenges.
Masterson TA; Tagawa ST
Urol Oncol; 2021 Sep; 39(9):561-568. PubMed ID: 33853746
[TBL] [Abstract][Full Text] [Related]
11. [Ultrasonics in urology. Historical review].
Espuela Orgaz R; Torres Martínez C; Martínez Torres JL; Hozujk Issa N
Arch Esp Urol; 1978; 31(2):187-204. PubMed ID: 358927
[No Abstract] [Full Text] [Related]
12. Next revolution in molecular theranostics: personalized medicine for urologic cancers.
Aoun F; Kourie HR; Artigas C; Roumeguère T
Future Oncol; 2015; 11(15):2205-19. PubMed ID: 26235183
[TBL] [Abstract][Full Text] [Related]
13. Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers.
Wood SL; Knowles MA; Thompson D; Selby PJ; Banks RE
Nat Rev Urol; 2013 Apr; 10(4):206-18. PubMed ID: 23443013
[TBL] [Abstract][Full Text] [Related]
14. Primary care update on kidney and bladder cancer: a urologic perspective.
Droller MJ
Med Clin North Am; 2004 Mar; 88(2):309-28, x. PubMed ID: 15049580
[TBL] [Abstract][Full Text] [Related]
15. [Significance of current bio- and molecular-markers in urological cancers].
Shimazui T; Akaza H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1008-14. PubMed ID: 15272577
[TBL] [Abstract][Full Text] [Related]
16. Controversies in urologic oncology.
Dreicer R; See W; Williams R
Iowa Med; 1991 Aug; 81(8):343-5. PubMed ID: 1938300
[No Abstract] [Full Text] [Related]
17. Annual review issue: Urologic pathology: a remarkable journey of innovation.
Cheng L; Berney DM
Histopathology; 2019 Jan; 74(1):3. PubMed ID: 30565305
[No Abstract] [Full Text] [Related]
18. Improving diagnosis of genitourinary cancers: Biomarker discovery strategies through mass spectrometry-based metabolomics.
Manzi M; Riquelme G; Zabalegui N; Monge ME
J Pharm Biomed Anal; 2020 Jan; 178():112905. PubMed ID: 31707200
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of extracellular vesicles as biomarkers for urogenital cancers.
Nawaz M; Camussi G; Valadi H; Nazarenko I; Ekström K; Wang X; Principe S; Shah N; Ashraf NM; Fatima F; Neder L; Kislinger T
Nat Rev Urol; 2014 Dec; 11(12):688-701. PubMed ID: 25403245
[TBL] [Abstract][Full Text] [Related]
20. [Tumor markers in urological malignancies].
Kuriyama M
Nihon Rinsho; 1996 Jun; 54(6):1631-6. PubMed ID: 8691621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
